LAVAL, QC, Sept. 9, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and CEO; Sam Eldessouky, senior vice president and corporate controller; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the virtual 18th Annual Morgan Stanley Global Healthcare Conference on Sept. 16, 2020 at 1:15 p.m. ET.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2020.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact:        




Media Contact:

Arthur Shannon    




Lainie Keller

arthur.shannon@bauschhealth.com 




lainie.keller@bauschhealth.com

(514) 856-3855    




(908) 927-1198

(877) 281-6642 (toll free)





 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-participate-at-the-18th-annual-morgan-stanley-global-healthcare-conference-301122454.html

SOURCE Bausch Health Companies Inc.

Copyright 2020 Canada NewsWire

Valeant Pharma (NYSE:VRX)
過去 株価チャート
から 5 2024 まで 6 2024 Valeant Pharmaのチャートをもっと見るにはこちらをクリック
Valeant Pharma (NYSE:VRX)
過去 株価チャート
から 6 2023 まで 6 2024 Valeant Pharmaのチャートをもっと見るにはこちらをクリック